Filing search / Ownership / PhaseBio Pharmaceuticals Inc / Page 3

8-K

7q6peyyw nedvz27ntu

8 Aug 22

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard

4:14pm

8-K

zookoqa y91ml7xq

5 Jul 22

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard

4:31pm

8-K

0ooe4 d8x5xcpe

20 May 22

Submission of Matters to a Vote of Security Holders

4:29pm

8-K

c9zknwbilsm

16 May 22

PhaseBio Pharmaceuticals Reports First Quarter 2022 Financial Results and Recent Business Highlights

12:00am

8-K

dusd2cjkrxaa egb

4 Apr 22

PhaseBio Announces Positive Results from Phase 2b Trial for Bentracimab

4:35pm

8-K

0yjhn1 gkrwtzrn

24 Mar 22

PhaseBio Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Recent Business Highlights

4:12pm

S-8

fufp7dw kcap2z

14 Jan 22

Registration of securities for employees

5:04pm

8-K

idsecf3q7z lny0xd

21 Dec 21

PhaseBio Provides Pemziviptadil (PB1046) Program Update

8:03am

8-K

8vdhqe

15 Nov 21

Regulation FD Disclosure

11:32am

424B5

skoh5t97h8yk

12 Nov 21

Prospectus supplement for primary offering

4:09pm

8-K

93w5ab43 1va

10 Nov 21

PhaseBio Reports Third-Quarter 2021 Financial Results and Recent Business Highlights

4:35pm

8-K

5z3571tqkqc

3 Nov 21

PhaseBio Announces Topline Results from Phase 2b Trial for Bentracimab

8:04am

8-K

2w1884

15 Sep 21

PhaseBio Appoints William D. Humphries to Board of Directors

8:04am

8-K

h5f o77guvfzdjk

12 Aug 21

PhaseBio Reports Second-Quarter 2021 Financial Results and Recent Business Highlights

10:11am

8-K

syv9 4h3ie

10 Aug 21

PhaseBio Pharmaceuticals and SFJ Pharmaceuticals® Announce Approval of IND Application in China for Bentracimab

8:03am